{
    "Trade/Device Name(s)": [
        "ARCHITECT Syphilis TP Reagent Kit",
        "ARCHITECT Syphilis TP Calibrator",
        "ARCHITECT Syphilis TP Controls"
    ],
    "Submitter Information": "Abbott Laboratories Diagnostics Division",
    "510(k) Number": "K153730",
    "Predicate Device Reference 510(k) Number(s)": [
        "K061247"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LIP",
        "JIT",
        "JJX"
    ],
    "Summary Letter Date": "May 20, 2016",
    "Summary Letter Received Date": "May 23, 2016",
    "Submission Date": "June 9, 2016",
    "Regulation Number(s)": [
        "21CFR866.3830",
        "21CFR862.1150",
        "21CFR862.1660"
    ],
    "Regulation Name(s)": [
        "Treponema pallidum treponemal test reagents",
        "Calibrator",
        "Control"
    ],
    "Analyte Class(es)": [
        "microbiology",
        "serology"
    ],
    "Analyte(s)": [
        "IgG antibodies to Treponema pallidum",
        "IgM antibodies to Treponema pallidum"
    ],
    "Specimen Type(s)": [
        "Serum",
        "Plasma"
    ],
    "Specimen Container(s)": [
        "Serum tube",
        "Serum separator tube",
        "Dipotassium EDTA tube",
        "Tripotassium EDTA tube",
        "Lithium heparin tube",
        "Lithium heparin plasma separator tube",
        "Sodium heparin tube"
    ],
    "Instrument(s)/Platform(s)": [
        "ARCHITECT i2000SR System",
        "ARCHITECT iSystem"
    ],
    "Method(s)/Technology(ies)": [
        "Chemiluminescent microparticle immunoassay (CMIA)"
    ],
    "Methodologies": [
        "Immunoassay",
        "Chemiluminescent detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Calibrator",
        "Control",
        "Reagent Kit"
    ],
    "Document Summary": "FDA 510(k) summary for ARCHITECT Syphilis TP assay for qualitative detection of IgG and IgM antibodies to Treponema pallidum in serum and plasma using CMIA technology",
    "Indications for Use Summary": "A chemiluminescent microparticle immunoassay for qualitative detection of IgG and IgM antibodies to Treponema pallidum in human serum and plasma, intended as an initial diagnostic test or in conjunction with a nontreponemal laboratory test and clinical findings to aid in the diagnosis of syphilis infection; not for donor screening use.",
    "fda_folder": "Microbiology"
}